XML 58 R64.htm IDEA: XBRL DOCUMENT v3.19.3
Commitment and Contingencies - Additional Information (Detail) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Jul. 31, 2019
May 31, 2019
Apr. 30, 2017
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Dec. 31, 2018
Feb. 28, 2017
Contingencies And Commitments [Line Items]                  
Research and development expense       $ 8,589,000 $ 6,158,000 $ 23,098,000 $ 15,657,000    
Sponsored Research Agreement                  
Contingencies And Commitments [Line Items]                  
Purchase commitment, amount     $ 499,000            
Purchase commitment, period     3 years            
Research and development expense       41,000   124,000      
Non-cancelable purchase commitments amount       98,000   98,000      
Non-cancelable purchase commitments amount, 2019       42,000   42,000      
Non-cancelable purchase commitments amount, 2020       56,000   56,000      
Termination notice period   30 days              
Maximum termination fees   $ 600,000              
Indemnification Agreements                  
Contingencies And Commitments [Line Items]                  
Accrued liabilities       $ 0   $ 0   $ 0  
Adimab Option and License Agreement                  
Contingencies And Commitments [Line Items]                  
Option fee including up front payment                 $ 250,000
Potential milestone payments $ 25,000,000